BA
RPRX icon

Bridgewater Associates’s Royalty Pharma RPRX Stock Holding History

Bridgewater Associates’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Buy
+219,687
New +$11.4M 0.05% 294
2025
Q1 		– Sell
-49,416
Closed -$1.26M – 780
2024
Q4 		$1.26M Buy
+49,416
New +$1.31M 0.01% 483
2024
Q3 		– Sell
-238,991
Closed -$6.3M – 905
2024
Q2 		$6.3M Sell
238,991
-132,471
-36% -$3.67M 0.03% 316
2024
Q1 		$11.3M Buy
371,462
+350,314
+1,656% +$10.3M 0.06% 237
2023
Q4 		$594K Sell
21,148
-172,028
-89% -$4.73M ﹤0.01% 690
2023
Q3 		$5.24M Buy
193,176
+80,538
+72% +$2.39M 0.03% 357
2023
Q2 		$3.46M Buy
112,638
+79,201
+237% +$2.68M 0.02% 379
2023
Q1 		$1.2M Sell
33,437
-5,656
-14% -$210K 0.01% 539
2022
Q4 		$1.54M Sell
39,093
-22,759
-37% -$950K 0.01% 573
2022
Q3 		$2.48M Buy
61,852
+56,543
+1,065% +$2.42M 0.01% 515
2022
Q2 		$223K Sell
5,309
-35,178
-87% -$1.44M ﹤0.01% 966
2022
Q1 		$1.58M Buy
40,487
+34,739
+604% +$1.36M 0.01% 726
2021
Q4 		$229K Buy
+5,748
New +$223K ﹤0.01% 716
2021
Q3 		– Sell
-18,347
Closed -$752K – 782
2021
Q2 		$752K Buy
+18,347
New +$780K ﹤0.01% 614
2021
Q1 		– Sell
-13,535
Closed -$677K – 587
2020
Q4 		$677K Buy
+13,535
New +$574K 0.01% 432

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bridgewater Associates's RPRX Position: Q2 2026 in Review

Bridgewater Associates opened a new position in Royalty Pharma (RPRX) in Q2 2026: 219,687 shares worth $12.3M. The stake represents 0.05% of the portfolio and ranks #294 among its holdings. This is a return to the name: Bridgewater Associates previously reported a position in RPRX as recently as Q4 2024.

Bridgewater Associates first reported a position in RPRX in Q4 2020 and has held it in 15 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Bridgewater Associates held 219,687 shares of Royalty Pharma worth $12.3M as of Q2 2026.
  • Royalty Pharma was a new Bridgewater Associates position in Q2 2026.
  • Royalty Pharma made up 0.05% of Bridgewater Associates's portfolio in Q2 2026, its #294 holding.
  • Bridgewater Associates first reported a position in Royalty Pharma in Q4 2020 and has held it in 15 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.